This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

HAEMATO Balance Sheet Health

Financial Health criteria checks 6/6

HAEMATO has a total shareholder equity of €149.5M and total debt of €335.0K, which brings its debt-to-equity ratio to 0.2%. Its total assets and total liabilities are €183.4M and €34.0M respectively. HAEMATO's EBIT is €9.2M making its interest coverage ratio -68.4. It has cash and short-term investments of €13.9M.

Key information

0.2%

Debt to equity ratio

€335.00k

Debt

Interest coverage ratio-68.4x
Cash€13.94m
Equity€149.45m
Total liabilities€34.00m
Total assets€183.45m

Recent financial health updates

Recent updates

What Is HAEMATO AG's (ETR:HAEK) Share Price Doing?

Feb 22
What Is HAEMATO AG's (ETR:HAEK) Share Price Doing?

Potential Upside For HAEMATO AG (ETR:HAEK) Not Without Risk

Jan 04
Potential Upside For HAEMATO AG (ETR:HAEK) Not Without Risk

The Returns At HAEMATO (ETR:HAEK) Aren't Growing

Sep 12
The Returns At HAEMATO (ETR:HAEK) Aren't Growing

HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20

May 20
HAEMATO's (ETR:HAEK) Dividend Will Be Increased To €1.20

We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)

May 12
We Like These Underlying Return On Capital Trends At HAEMATO (ETR:HAEK)

HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher

Dec 08
HAEMATO's (ETR:HAEK) Returns On Capital Are Heading Higher

The Strong Earnings Posted By HAEMATO (ETR:HAEK) Are A Good Indication Of The Strength Of The Business

May 24
The Strong Earnings Posted By HAEMATO (ETR:HAEK) Are A Good Indication Of The Strength Of The Business

HAEMATO (ETR:HAEK) Hasn't Managed To Accelerate Its Returns

Nov 17
HAEMATO (ETR:HAEK) Hasn't Managed To Accelerate Its Returns

HAEMATO (ETR:HAEK) Will Be Hoping To Turn Its Returns On Capital Around

May 30
HAEMATO (ETR:HAEK) Will Be Hoping To Turn Its Returns On Capital Around

We're Not Very Worried About HAEMATO's (ETR:HAEK) Cash Burn Rate

Mar 08
We're Not Very Worried About HAEMATO's (ETR:HAEK) Cash Burn Rate

What Do The Returns At HAEMATO (ETR:HAEK) Mean Going Forward?

Feb 15
What Do The Returns At HAEMATO (ETR:HAEK) Mean Going Forward?

Estimating The Fair Value Of HAEMATO AG (ETR:HAEK)

Jan 25
Estimating The Fair Value Of HAEMATO AG (ETR:HAEK)

Is Now An Opportune Moment To Examine HAEMATO AG (ETR:HAEK)?

Jan 04
Is Now An Opportune Moment To Examine HAEMATO AG (ETR:HAEK)?

Reflecting on HAEMATO's (ETR:HAEK) Share Price Returns Over The Last Three Years

Dec 14
Reflecting on HAEMATO's (ETR:HAEK) Share Price Returns Over The Last Three Years

Financial Position Analysis

Short Term Liabilities: HAEK's short term assets (€77.3M) exceed its short term liabilities (€31.4M).

Long Term Liabilities: HAEK's short term assets (€77.3M) exceed its long term liabilities (€2.6M).


Debt to Equity History and Analysis

Debt Level: HAEK has more cash than its total debt.

Reducing Debt: HAEK's debt to equity ratio has reduced from 36.2% to 0.2% over the past 5 years.

Debt Coverage: HAEK's debt is well covered by operating cash flow (3382.7%).

Interest Coverage: HAEK earns more interest than it pays, so coverage of interest payments is not a concern.


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/05/28 19:58
End of Day Share Price 2024/02/29 00:00
Earnings2023/06/30
Annual Earnings2022/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

HAEMATO AG is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Edward AcklinFirst Berlin Equity Research GmbH
Cosmin FilkerGBC AG
Christian EhmannWarburg Research GmbH